Crossover Fund Lp Bioasia serves as Executive at BIOFORM MEDICAL INC, where they oversee executive responsibilities. Since joining the company, Crossover Fund Lp Bioasia has executed 3 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 19, 2010 involved selling 198,487 shares valued at $1.1M.
Crossover Fund Lp Bioasia currently holds 1,209,057 shares of BIOFORM MEDICAL INC (BFRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Crossover Fund Lp Bioasia has been a net seller of BFRM stock. They have purchased $0 and sold $1.4M worth of shares.
Crossover Fund Lp Bioasia's most recent insider trade was on Jan 19, 2010, when they sold 198,487 shares at $5.51 per share.
Get notified when new Form 4 filings are submitted
| $5.51 |
| Discretionary |
| Jan 19, 2010 | BFRM | $20.2K | Sale | 3,669 | $5.51 | Discretionary |